文献
J-GLOBAL ID:201802267164437594
整理番号:18A1263400
ダサチニブは,TAZ活性の阻害を介してマイトジェン活性化蛋白質キナーゼ阻害剤に対するKRAS変異体癌細胞を感作する【JST・京大機械翻訳】
Dasatinib sensitises KRAS-mutant cancer cells to mitogen-activated protein kinase kinase inhibitor via inhibition of TAZ activity
著者 (6件):
Rao Guanhua
(Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
,
Kim In-kyu
(Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
,
Conforti Fabio
(Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
,
Liu Jing
(Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
,
Zhang Yu-Wen
(Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
,
Giaccone Giuseppe
(Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
99
ページ:
37-48
発行年:
2018年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)